Nanoparticles-encapsulated doxorubicin alleviates drug resistance of osteosarcoma via inducing ferroptosis

References

• Ali, M. 2023. “What Function of Nanoparticles is the Primary Factor for Their Hyper-Toxicity?” Advances in Colloid and Interface Science 314: 102881. https://doi.org/10.1016/j.cis.2023.102881.
   PubMed Web of Science ®Google Scholar
• Ashley, N., and J. Poulton. 2009. “Mitochondrial DNA is a Direct Target of Anti-Cancer Anthracycline Drugs.” Biochemical and Biophysical Research Communications 378 (3): 450–455. https://doi.org/10.1016/j.bbrc.2008.11.059.
   PubMed Web of Science ®Google Scholar
• Carvalho, Cristina, Renato X. Santos, Susana Cardoso, Sónia Correia, Paulo J. Oliveira, Maria S. Santos, Paula I. Moreira, et al. 2009. “Doxorubicin: The Good, the Bad and the Ugly Effect.” Current Medicinal Chemistry 16 (25): 3267–3285. https://doi.org/10.2174/092986709788803312.
   PubMed Web of Science ®Google Scholar
• Corre, Isabelle, Franck Verrecchia, Vincent Crenn, Francoise Redini, and Valérie Trichet. 2020. “The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem.” Cells 9 (4): 976. https://doi.org/10.3390/cells9040976.
   PubMed Web of Science ®Google Scholar
• Fleisher, Brett, Jovin Lezeau, Carolin Werkman, Brehanna Jacobs, and Sihem Ait-Oudhia. 2021. “In Vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach.” Breast Cancer (Dove Medical Press) 13: 87–105. https://doi.org/10.2147/BCTT.S292161.
   PubMed Web of Science ®Google Scholar
• Gabizon, A. A., Y. Patil, and N. M. La-Beck. 2016. “New Insights and Evolving Role of Pegylated Liposomal Doxorubicin in Cancer Therapy.” Drug Resistance Updates: reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 29: 90–106. https://doi.org/10.1016/j.drup.2016.10.003.
   PubMed Web of Science ®Google Scholar
• Hung, Chih-Chiang, Youngsen Yang, I-Chen Tsai, Chiann-Yi Hsu, Chia-Hua Liu, and Jie-Ru Yang. 2020. “The Efficacy of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Case-Control Study in Taiwan.” Biochemistry Research International 2020: 5729389–5729389. https://doi.org/10.1155/2020/5729389.
   PubMed Web of Science ®Google Scholar
• Kansara, Maya, Michele W. Teng, Mark J. Smyth, and David M. Thomas. 2014. “Translational Biology of Osteosarcoma.” Nature Reviews. Cancer 14 (11): 722–735. https://doi.org/10.1038/nrc3838.
   PubMed Web of Science ®Google Scholar
• Kim, Kyoung Sub., Kenichi Suzuki, Hana Cho, Yu Seok Youn, and You Han Bae. 2018. “Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport.” ACS Nano 12 (9): 8893–8900. https://doi.org/10.1021/acsnano.8b04315.
   PubMed Web of Science ®Google Scholar
• Li, D., and Y. Li. 2020. “The Interaction between Ferroptosis and Lipid Metabolism in Cancer.” Signal Transduction and Targeted Therapy 5 (1): 108. https://doi.org/10.1038/s41392-020-00216-5.
   PubMed Web of Science ®Google Scholar
• Lin, G., and M. Zhang. 2023. “Ligand Chemistry in Antitumor Theranostic Nanoparticles.” Accounts of Chemical Research 56 (12): 1578–1590. https://doi.org/10.1021/acs.accounts.3c00151.
   PubMed Web of Science ®Google Scholar
• Nakashima, M., N. Suga, Y. Ikeda, S. Yoshikawa, and S. Matsuda. 2024. “Relevant MicroRNAs of MMPs and TIMPs with Certain Gut Microbiota Could Be Involved in the Invasiveness and Metastasis of Malignant Tumors.” Innovation Discovery 1 (2): 10. https://doi.org/10.53964/id.2024010.
   Google Scholar
• Ott, Martin, John D. Robertson, Vladimir Gogvadze, Boris Zhivotovsky, and Sten Orrenius. 2002. “Cytochrome c Release from Mitochondria Proceeds by a Two-Step Process.” Proceedings of the National Academy of Sciences of the United States of America 99 (3): 1259–1263. https://doi.org/10.1073/pnas.241655498.
   PubMed Web of Science ®Google Scholar
• Poh, Han Ming, Yi Shiou Chiou, Qing Yun Chong, Ru-Mei Chen, Kanchugarakoppal S. Rangappa, Lan Ma, Tao Zhu, et al. 2019. “Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma.” Cancers 11 (10): 1528. https://doi.org/10.3390/cancers11101528.
   PubMed Web of Science ®Google Scholar
• Rau, Kun-Ming, Yung-Chang Lin, Yen-Yang Chen, Jen-Shi Chen, Kuan-Der Lee, Cheng-Hsu Wang, Hsien-Kun Chang, et al. 2015. “Pegylated Liposomal Doxorubicin (Lipo-Dox®) Combined with Cyclophosphamide and 5-Fluorouracil is Effective and Safe as Salvage Chemotherapy in Taxane-Treated Metastatic Breast Cancer: An Open-Label, Multi-Center, Non-Comparative Phase II Study.” BMC Cancer 15 (1): 423. https://doi.org/10.1186/s12885-015-1433-4.
   PubMedGoogle Scholar
• Shan, Jiang, Ding Xiaoqian, Li Xia, Wang Yu, Zheng Zhilong, Shi Zhihui, Qin Yanjie, et al. 2022. “Oxidative Stress, Autophagy, and Apoptosis Induced by Doxycycline in Loach Fin Cells in Vitro.” Science of the Total Environment 839: 156379. https://doi.org/10.1016/j.scitotenv.2022.156379.
   PubMed Web of Science ®Google Scholar
• Shoaib, Z., T. M. Fan, and J. M. K. Irudayaraj. 2022. “Osteosarcoma Mechanobiology and Therapeutic Targets.” British Journal of Pharmacology 179 (2): 201–217. https://doi.org/10.1111/bph.15713.
   PubMed Web of Science ®Google Scholar
• Xie, Y., W. Hou, X. Song, Y. Yu, J. Huang, X. Sun, R. Kang, et al. 2016. “Ferroptosis: Process and Function.” Cell Death and Differentiation 23 (3): 369–379. https://doi.org/10.1038/cdd.2015.158.
   PubMed Web of Science ®Google Scholar
• Yan, Yuelong, Hongqi Teng, Qinglei Hang, Lavanya Kondiparthi, Guang Lei, Amber Horbath, Xiaoguang Liu, et al. 2023. “SLC7A11 Expression Level Dictates Differential Responses to Oxidative Stress in Cancer Cells.” Nature Communications 14 (1): 3673. https://doi.org/10.1038/s41467-023-39401-9.
   PubMed Web of Science ®Google Scholar
• Yang, Chaofei, Ye Tian, Fan Zhao, Zhihao Chen, Peihong Su, Yu Li, Airong Qian, et al. 2020. “Bone Microenvironment and Osteosarcom a Metastasis.” International Journal of Molecular Sciences 21 (19): 6985. https://doi.org/10.3390/ijms21196985.
   PubMed Web of Science ®Google Scholar
• Zhang, Chen, Xinyin Liu, Shidai Jin, Yi Chen, and Renhua Guo. 2022. “Ferroptosis in Cancer Therapy: A Novel Approach to Reversing Drug Resistance.” Molecular Cancer 21 (1): 47. https://doi.org/10.1186/s12943-022-01530-y.
   PubMed Web of Science ®Google Scholar